These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 16697480

  • 1. Mechanism of action, development and clinical experience of recombinant FVIIa.
    Hedner U.
    J Biotechnol; 2006 Aug 05; 124(4):747-57. PubMed ID: 16697480
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of action of factor VIIa in the treatment of coagulopathies.
    Hedner U.
    Semin Thromb Hemost; 2006 Apr 05; 32 Suppl 1():77-85. PubMed ID: 16673269
    [Abstract] [Full Text] [Related]

  • 3. General haemostatic agents--fact or fiction?
    Hedner U.
    Pathophysiol Haemost Thromb; 2002 Apr 05; 32 Suppl 1():33-6. PubMed ID: 12214145
    [Abstract] [Full Text] [Related]

  • 4. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U, Erhardtsen E.
    Clin Adv Hematol Oncol; 2003 Feb 05; 1(2):112-9. PubMed ID: 16224390
    [Abstract] [Full Text] [Related]

  • 5. Recombinant factor VIIa: its background, development and clinical use.
    Hedner U.
    Curr Opin Hematol; 2007 May 05; 14(3):225-9. PubMed ID: 17414211
    [Abstract] [Full Text] [Related]

  • 6. The effect of platelets on fibrin gel structure formed in the presence of recombinant factor VIIa in hemophilia plasma and in plasma from a patient with Glanzmann thrombasthenia.
    He S, Ekman GJ, Hedner U.
    J Thromb Haemost; 2005 Feb 05; 3(2):272-9. PubMed ID: 15670032
    [Abstract] [Full Text] [Related]

  • 7. First 20 years with recombinant FVIIa (NovoSeven).
    Hedner U, Lee CA.
    Haemophilia; 2011 Jan 05; 17(1):e172-82. PubMed ID: 20609014
    [Abstract] [Full Text] [Related]

  • 8. The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX.
    He S, Blombäck M, Jacobsson Ekman G, Hedner U.
    J Thromb Haemost; 2003 Jun 05; 1(6):1215-9. PubMed ID: 12871322
    [Abstract] [Full Text] [Related]

  • 9. History of rFVIIa therapy.
    Hedner U.
    Thromb Res; 2010 Apr 05; 125 Suppl 1():S4-6. PubMed ID: 20188400
    [Abstract] [Full Text] [Related]

  • 10. FVIIa as therapeutic agent in hemophilia and beyond.
    Hedner U.
    Front Biosci (Elite Ed); 2012 Jan 01; 4(4):1210-23. PubMed ID: 22201947
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
    Hoffman M, Monroe DM.
    Dis Mon; 2003 Jan 01; 49(1):14-21. PubMed ID: 12525825
    [Abstract] [Full Text] [Related]

  • 16. Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.
    Allen GA, Hoffman M, Roberts HR, Monroe DM.
    Can J Anaesth; 2002 Dec 01; 49(10):S7-14. PubMed ID: 12546000
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.